Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benson A. B., 3rd, Trump D. L., Koeller J. M., Egorin M. I., Olman E. A., Witte R. S., Davis T. E., Tormey D. C. Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):795–799. [PubMed] [Google Scholar]
- Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987 Feb 15;47(4):936–942. [PubMed] [Google Scholar]
- Dowsett M., Harris A. L., Stuart-Harris R., Hill M., Cantwell B. M., Smith I. E., Jeffcoate S. L. A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. Br J Cancer. 1985 Oct;52(4):525–529. doi: 10.1038/bjc.1985.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamann S. R., Todd G. D., McAllister R. G., Jr The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog. Pharmacology. 1983;27(1):1–8. doi: 10.1159/000137823. [DOI] [PubMed] [Google Scholar]
- Kaye S., Merry S. Tumour cell resistance to anthracyclines--a review. Cancer Chemother Pharmacol. 1985;14(2):96–103. doi: 10.1007/BF00434344. [DOI] [PubMed] [Google Scholar]
- Merry S., Kaye S. B., Freshney R. I. Cross-resistance to cytotoxic drugs in human glioma cell lines in culture. Br J Cancer. 1984 Dec;50(6):831–835. doi: 10.1038/bjc.1984.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neugebauer G. Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog. Cardiovasc Res. 1978 Apr;12(4):247–254. doi: 10.1093/cvr/12.4.247. [DOI] [PubMed] [Google Scholar]
- Ozols R. F., Cunnion R. E., Klecker R. W., Jr, Hamilton T. C., Ostchega Y., Parrillo J. E., Young R. C. Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol. 1987 Apr;5(4):641–647. doi: 10.1200/JCO.1987.5.4.641. [DOI] [PubMed] [Google Scholar]
- Slater L. M., Murray S. L., Wetzel M. W., Wisdom R. M., DuVall E. M. Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. J Clin Invest. 1982 Nov;70(5):1131–1134. doi: 10.1172/JCI110702. [DOI] [PMC free article] [PubMed] [Google Scholar]